Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Market overview PART 07: Market segmentation by end-user • Market overview • Hospitals and clinics • ASCs PART 08: Geographical segmentation • EP therapeutic devices market in Americas • EP therapeutic devices market in EMEA • EP therapeutic devices market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Development of leadless pacemaker • Increased adoption of multi-functional pacemakers PART 12: Vendor landscape • Competitive scenario PART 13: Key vendor analysis • Boston Scientific • Medtronic • St. Jude Medical • Key companies to watch • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits  Exhibit 01: Global EP therapeutic devices market 2016-2021: Overview Exhibit 02: Global EP therapeutic devices market 2016-2021 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Global EP therapeutic devices market 2016 by product: Overview Exhibit 05: Global ICD market 2016-2021: Overview Exhibit 06: Global ICD market 2016-2021 ($ billions) Exhibit 07: Major players in global ICD market 2016 Exhibit 08: Global cardiac pacemakers market 2016-2021: Overview Exhibit 09: Global cardiac pacemakers market 2016-2021 ($ billions) Exhibit 10: Major players in global cardiac pacemakers market 2016 Exhibit 11: Global CRT devices market 2016-2021: Overview Exhibit 12: Global CRT devices market 2016-2021 ($ billions) Exhibit 13: Major players in the CRT devices market 2016 Exhibit 14: Global ablation catheters market 2016-2021: Overview Exhibit 15: Global ablation catheters market 2016-2021 ($ billions) Exhibit 16: Major players in global ablation catheters market 2016 Exhibit 17: Global EP therapeutic devices market by end-users 2016: Overview Exhibit 18: EP therapeutic devices market in Americas 2016-2021: Overview Exhibit 22: EP therapeutic devices market in Americas 2016-2021 ($ billions) Exhibit 19: Americas: Market metrics in various countries Exhibit 20: EP therapeutic devices market in EMEA 2016-2021: Overview Exhibit 21: EP therapeutic devices market in EMEA 2016-2021 ($ billions) Exhibit 22: EMEA: Market metrics in various countries Exhibit 23: Pacemaker implant centers in major European countries Exhibit 24: Total number of pacemakers implanted in major European countries Exhibit 25: Number of first implants and replacements for pacemaker in 2014 Exhibit 26: Number of first implants and replacements for pacemaker in 2015 Exhibit 27: CRT devices implant centers in major European countries Exhibit 28: Total number of CRT devices implanted in major European countries Exhibit 29: ICD implantation centers in major European countries Exhibit 30: Total number of ICD implanted in major European countries Exhibit 31: Number of ablation procedures performed in major European countries Exhibit 32: Number of atrial fibrillation ablation procedures in major European countries Exhibit 33: Insurance modality in major European countries 2014 Exhibit 34: Insurance modality in major European countries 2015 Exhibit 35: EP therapeutic devices market in APAC 2016-2021: Overview Exhibit 36: EP therapeutic devices market in APAC 2016-2021 ($ billions) Exhibit 37: APAC: Market metrics in various countries Exhibit 38: Factors affecting adoption of remote monitoring devices Exhibit 39: Competitive structure analysis of global EP therapeutic devices market 2016 Exhibit 40: Competitive landscape analysis of global EP therapeutic devices market (2016) Exhibit 41: Strategic success factors of companies in global EP therapeutic devices market 2016 Exhibit 42: Boston Scientific: Key highlights Exhibit 43: Boston Scientific: Strength analysis Exhibit 44: Boston Scientific: Strategy assessment Exhibit 45: Boston Scientific: Opportunity assessment Exhibit 46: Medtronic: Key highlights Exhibit 47: Medtronic: Strength analysis Exhibit 48: Medtronic: Strategy assessment Exhibit 49: Medtronic: Opportunity assessment Exhibit 50: St. Jude Medical: Key highlights Exhibit 51: St. Jude Medical: Strength assessment Exhibit 52: St. Jude Medical: Strategy assessment Exhibit 53: St. Jude Medical: Opportunity assessment Exhibit 54: Koninklijke Philips: Company analysis

Boston Scientific, Medtronic, St. Jude Medical, AngioDynamics, Biosense Webster, BIOTRONIK, Cardiac Science, Cook Medical, GE Healthcare, Imricor, LivaNova, Maquet Getinge Group (Atrium Medical), MicroPortScientific, and Vimecon.